2025 Focused Update of the 2019 ESC/EAS Guidelines for the administration of dyslipidaemias

This web page was created programmatically, to learn the article in its unique location you possibly can go to the hyperlink bellow:
https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Focused-Update-on-Dyslipidaemias
and if you wish to take away this text from our web site please contact us



ESC Clinical Practice Guidelines

This 2025 Focused Update addresses modifications in suggestions for the remedy of dyslipidaemias based mostly on new proof revealed because the 2019 model, up till 31 March 2025.

The Task Force additionally thought-about and mentioned: mixture remedy with high-dose statin plus ezetimibe and intensification of lipid-lowering remedy in the course of the index hospitalization for sufferers presenting with acute coronary syndrome (ACS), in addition to new knowledge on lipoprotein(a) [Lp(a)] as a threat modifier.

Only outcomes that will result in new or modified Class I/IIa or Class III suggestions had been chosen for inclusion in Recommendation Tables.

Coronary Artery Disease (Chronic)

Cardiovascular Disease in Primary Care

Rehabilitation and Sports Cardiology

Basic Science

Treatment

Hypertension

Lipids

Risk Factors and Prevention

Cardiovascular Pharmacotherapy


This web page was created programmatically, to learn the article in its unique location you possibly can go to the hyperlink bellow:
https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Focused-Update-on-Dyslipidaemias
and if you wish to take away this text from our web site please contact us

Leave a Reply

Your email address will not be published. Required fields are marked *